Alrista 150mg Sr Strip Of 10 Tablets
10 Tablet(s) in StripMRP ₹174.37
₹144.73
17% OFF
Made by
MACLEODS PHARMACEUTICALS
Dosage
TABLET
Expiry
Product Summary
| Salt Content | Epalrestat(150.0 Mg) |
| Uses | Decreases cholesterol absorption, dissolves cholesterol gallstones |
| Therapy | Drugs for diabetic neuropathy |
| Side effects | Diarrhoea, high creatinine, high blood sugar, peptic ulcer, skin rash |
Assurance
available
Regulated
Medical Description
Uses
- Diabetic peripheral neuropathy
Contraindications
- If you are allergic to epalrestat
Side effects
- Fever
- Nausea
- Diarrhea
- Increases in liver enzymes
- Skin rashes
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You have allergy to this medicine
Directions for Use
Storage and disposal
Dosage
Overdose
Missed a Dose
Mode of Action
How Does It Work?
Frequently Asked Questions (FAQs)
Articles
View All
Chronic Condition Articles
View All
Did you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:ALRISTA
Manufacturer Name:MACLEODS PHARMACEUTICALS
Address:Macleods Pharmaceuticals Ltd. Khasra No. 21,22,66,67 & 68, Aho-Yangtam Namchepung, Po: Ranipool Sikkim-737135
Country of Origin:India
Vendor Details
Fulfillment Information: Alrista Sr 150 MG Tablet (10) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
References:
- Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDG - Full Text View - ClinicalTrials.gov [Internet]. Clinicaltrials.gov. 2021 [cited 09 Jan 2026].
- Calabek B, Callaghan B, Feldman EL. Therapy for diabetic neuropathy. Diabetes and the Nervous System [Internet]. Sciencedirect.com. 2014 [cited 09 Jan 2026];317–33.
- Hotta N, Akanuma Y, Kawamori R, Matsuoka K, Oka Y, Shichiri M, Toyota T, Nakashima M, Yoshimura I, Sakamoto N, Shigeta Y. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial. Diabetes care. 2006 Jul 1;29(7):1538-44.
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
